Medicine & Life Sciences
T-Cell Lymphoma
100%
Stem Cell Transplantation
67%
Survival
66%
Busulfan
58%
Graft vs Host Disease
53%
Peripheral T-Cell Lymphoma
52%
Transplants
52%
Large Granular Lymphocytic Leukemia
47%
T-Lymphocytes
46%
fludarabine
46%
Allogeneic Cells
41%
Chimeric Antigen Receptors
41%
romidepsin
40%
Hematologic Neoplasms
39%
Cell- and Tissue-Based Therapy
37%
Lymphoma
36%
Progression-Free Survival
34%
Cell Transplantation
33%
Recurrence
32%
Hematopoietic Stem Cells
29%
Therapeutics
28%
Cyclophosphamide
28%
Natural Killer T-Cells
27%
Non-Hodgkin's Lymphoma
27%
Lymphoma, Large B-Cell, Diffuse
26%
Whole-Body Irradiation
25%
axicabtagene ciloleucel
24%
B-Cell Lymphoma
23%
Cutaneous T-Cell Lymphoma
22%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21%
Hodgkin Disease
21%
Transplantation
21%
Incidence
20%
liposomal doxorubicin
20%
Hematopoietic Stem Cell Transplantation
20%
Melphalan
20%
Thrombotic Microangiopathies
20%
Neoplasms
19%
MEDI-570
18%
Cytokine Release Syndrome
18%
Small Cell Carcinoma
17%
Methotrexate
17%
Anaplastic Large-Cell Lymphoma
16%
Mortality
16%
gemcitabine
16%
Haploidentical Transplantation
16%
Interleukin-15
15%
Confidence Intervals
15%
Unrelated Donors
15%
Cytokines
15%